Ignite Creation Date:
2024-05-06 @ 4:58 PM
Last Modification Date:
2024-10-26 @ 2:19 PM
Study NCT ID:
NCT05143996
Status:
RECRUITING
Last Update Posted:
2023-12-27
First Post:
2021-10-26
Brief Title:
CLN-049 in Patients With RelapsedRefractory Acute Myeloid Leukemia AML or Myelodysplastic Syndrome MDS
Sponsor:
Cullinan Therapeutics Inc
Organization:
Cullinan Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-18
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-11
Completion Date Type:
ESTIMATED
First Submit Date:
2021-10-26
First Submit QC Date:
December 2 2021
Study First Post Date:
2021-12-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-22
Last Update Post Date:
2023-12-27
Last Update Post Date Type:
ACTUAL